Stop Tb Partnership's Global Drug Facility (GDF) announced in a virtual press event on 30 August price reductions up to 55% for bedaquiline, a critical drug used to treat drug-resistant TB (DR-TB)
The news of the price drop attracted a lot of media attention again from top-tier media outlets and generated below listed coverage:
